Enhanced Efficacy of Direct-Acting Antivirals in Hepatitis C Patients by Coadministration of Black Cumin and Ascorbate as Antioxidant Adjuvants

Table 3

Genotyping frequencies of HCV positive patients in control and treatment groups.

Groups	HCV genotype	Frequency (%)
Control	3a	14 (93.33)
Control	2b	1 (0.066)
Treatment	3a	13 (86.66)
Treatment	2b	2 (1.33)